Personal BP - CAI Study

Part of paid clinical trials in Evanston, Illinois.

Sponsor
Edwards Lifesciences
Study ID
NCT06492746
Status
Recruiting
Apply to this trial

Conditions

  • Blood Pressure

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring — DEVICE
    The arterial line with Acumen IQ sensor and Foresight Elite sensor will be connected to the HemoSphere monitor with laptop displaying the CAI parameter.

Study Details

A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets

Key Dates

Start date
Jun 3, 2024
Status verified
Jul 2025
Primary completion
Nov 30, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
120 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Cardiopulmonary bypass patients receiving blood pressure and oximetry monitoring

Primary Outcome Measure

To determine the magnitude and duration of CAI [ Time Frame: Duration of the procedure through 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Northwestern University HospitalEvanstonIllinois60611
Bin Zhang

Find similar trials in Evanston, IL

By research site
Northwestern University Hospital· Evanston, IL

Related Studies